scispace - formally typeset
G

Gordon Y.S. Choi

Researcher at The Chinese University of Hong Kong

Publications -  30
Citations -  1877

Gordon Y.S. Choi is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Renal replacement therapy & Dosing. The author has an hindex of 15, co-authored 29 publications receiving 1516 citations. Previous affiliations of Gordon Y.S. Choi include St. John's Medical College.

Papers
More filters
Journal ArticleDOI

Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes

Fernando Botto, +294 more
- 01 Mar 2014 - 
TL;DR: Among adults undergoing noncardiac surgery, MINS was an independent predictor of 30-day mortality and had the highest population-attributable risk of the perioperative complications.
Journal ArticleDOI

Principles of antibacterial dosing in continuous renal replacement therapy.

TL;DR: Basic principles and relevant data are provided to guide the clinician in prescribing individualized dosing regimes and results in considerable inter- and intrapatient heterogeneity in dose requirements.
Journal ArticleDOI

Principles of antibacterial dosing in continuous renal replacement therapy.

TL;DR: Individualized dosing based on first principles may be the most appropriate method of dosing, particularly when enhanced by therapeutic drug monitoring.
Journal ArticleDOI

Autophagy in sepsis: Degradation into exhaustion?

TL;DR: The role ofAutophagy modulation appears to be protective against multiple organ injuries in these murine sepsis models and the therapeutic potential of autophagy enhancers is discussed.
Journal ArticleDOI

A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data?

TL;DR: An ideal dataset was established of the parameters that should be reported when calculating a drug dosing regimen from first principles for patients with acute renal failure receiving CRRT and it is hoped this dataset will be a useful guide when reporting future pharmacokinetic data.